NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Women's Screening and Self-Testing Program (PROMETA) Study

RecruitingNA

Sponsor: Tulane University

Conditions: Human Papilloma Virus Related Cervical Carcinoma

Interventions: HPV DNA testing be self-collected vaginal swab

Countries: Mozambique

This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.

Eligibility overview

Sex: FEMALE

Age: 25 Years to 49 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Women 25-49 years
* Accessing HIV care and treatment services
* Not being pregnant
* Patients with a cervix

Exclusion Criteria:

* Physical or mental impairment that inhibits participation in the study
* Pregnant women or \<6 weeks post-partum
* Women who have undergone a total hysterectomy with removal of the cervix

Locations (1)

Maputo, Mozambique